New Project To Develop Consensus-Based Outcomes For Trials Targeting Rare Skin Condition
Executive Summary
An international project that aims to develop a harmonized framework on the minimum aspects that should be measured and reported in clinical trials for the genetic skin disorder, epidermolysis bullosa, has drawn the European Medicines Agency’s attention.